Developing soft-robotic implants to support failing hearts without blood contact
Heart failure can be life-threatening, while heart transplantation is limited by the availability of donor organs. Ventricular assist devices provide mechanical support but expose patients to blood-related complications, creating a need for alternative ways to assist the failing heart.
Cambridge CardioMatrix is developing a soft-robotic implant that supports the heart from its outer surface without contacting blood. Its flexible hydraulic network is designed to combine continuous sensing with adjustable mechanical assistance for heart failure.
What stands out about Cambridge CardioMatrix
Reports improved cardiac output and reversal of adverse ventricular remodelling with its ASD cardiac support system in rodent models.
Won the 2026 Bronze Award at the Future City International Medical & Healthcare Technology Innovation Competition in Xiong’an, China.
Get a curated pipeline of healthcare and life sciences startups aligned with your investment thesis.